Mismatch-negativity (MMN) is regarded as one of the most highly translatable studies around. It has proven invaluable in the field for developing drugs for schizophrenia.

What is MMN?

Mismatch negativity (MMN) is a negative component of the event-related response in an EEG signal, elicited by any perceptible change in some repetitive aspect of an auditory stimulation.

What we do?

We've applied our expertise in EEG to develop rodent mismatch negativity (MMN). We can conduct strict clinical research studies under specified conditions and provide you with reliable, quality data.

Contact us today to discuss your project requirements and get things underway: Tel: +44 (0)20 7691 0984 or This email address is being protected from spambots. You need JavaScript enabled to view it.

Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60



Copyright © 2020 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design


The first International Association for the Study of Pain, (IASP) virtual conference is live!

Come and visit Transpharmation’s booth #iaspvirtualseries

View our latest specialist poster on pain; ‘The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type 1 diabetic rodents’ and find out more about our wide-ranging pain expertise.  We look forward to seeing you there.

IASP Footer